Nouri Neamati

3.0k total citations
50 papers, 2.5k citations indexed

About

Nouri Neamati is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nouri Neamati has authored 50 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Organic Chemistry and 18 papers in Oncology. Recurrent topics in Nouri Neamati's work include HIV/AIDS drug development and treatment (9 papers), Synthesis and biological activity (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Nouri Neamati is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Synthesis and biological activity (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). Nouri Neamati collaborates with scholars based in United States, Italy and India. Nouri Neamati's co-authors include Fedora Grande, Shili Xu, Antonio Garofalo, Bikash Debnath, Xiaohong Chen, Carmen Plasencia, Jinxia Deng, Raveendra Dayam, Yingping Hou and Francesca Aiello and has published in prestigious journals such as Molecular Cell, Bioinformatics and PLoS ONE.

In The Last Decade

Nouri Neamati

50 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nouri Neamati United States 26 1.1k 923 635 302 276 50 2.5k
John A. Flygare United States 26 2.3k 2.1× 907 1.0× 679 1.1× 647 2.1× 134 0.5× 44 3.4k
Renato T. Skerlj United States 31 1.0k 0.9× 1.3k 1.4× 926 1.5× 849 2.8× 245 0.9× 68 2.9k
Jeremy Green United States 26 1.4k 1.2× 298 0.3× 828 1.3× 316 1.0× 290 1.1× 51 2.4k
Jennifer L. Meagher United States 33 2.2k 2.0× 708 0.8× 453 0.7× 349 1.2× 88 0.3× 53 2.9k
Joseph M. Covey United States 29 2.4k 2.1× 802 0.9× 320 0.5× 234 0.8× 122 0.4× 88 3.0k
William T. Windsor United States 23 1.5k 1.3× 876 0.9× 302 0.5× 370 1.2× 157 0.6× 42 2.5k
Naoyuki Kanzaki Japan 27 1.2k 1.0× 646 0.7× 570 0.9× 634 2.1× 462 1.7× 47 2.9k
László Őrfi Hungary 31 1.6k 1.4× 1.0k 1.1× 539 0.8× 335 1.1× 358 1.3× 113 3.3k
Cy A. Stein United States 23 1.6k 1.4× 351 0.4× 148 0.2× 177 0.6× 123 0.4× 51 2.3k
Anne M. Hassell United States 21 1.6k 1.4× 1.0k 1.1× 585 0.9× 208 0.7× 110 0.4× 32 2.9k

Countries citing papers authored by Nouri Neamati

Since Specialization
Citations

This map shows the geographic impact of Nouri Neamati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nouri Neamati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nouri Neamati more than expected).

Fields of papers citing papers by Nouri Neamati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nouri Neamati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nouri Neamati. The network helps show where Nouri Neamati may publish in the future.

Co-authorship network of co-authors of Nouri Neamati

This figure shows the co-authorship network connecting the top 25 collaborators of Nouri Neamati. A scholar is included among the top collaborators of Nouri Neamati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nouri Neamati. Nouri Neamati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Shili, Helty Adisetiyo, Shuzo Tamura, et al.. (2015). Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer. British Journal of Cancer. 113(2). 242–251. 29 indexed citations
2.
Jali, Bigyan Ranjan, Yuting Kuang, Nouri Neamati, & J.B. Baruah. (2014). Selective binding of naphthoquinone derivatives to serum albumin proteins and their effects on cytotoxicity. Chemico-Biological Interactions. 214. 10–17. 28 indexed citations
3.
Arunasree, Kalle M., et al.. (2014). Design, Synthesis and Screening Studies of Potent Thiazol-2-Amine Derivatives as Fibroblast Growth Factor Receptor 1 Inhibitors. Current Topics in Medicinal Chemistry. 14(17). 2031–2041. 4 indexed citations
4.
Xu, Shili, Fedora Grande, Antonio Garofalo, & Nouri Neamati. (2013). Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer. Molecular Cancer Therapeutics. 12(6). 937–949. 105 indexed citations
5.
Debnath, Bikash, Shili Xu, Fedora Grande, Antonio Garofalo, & Nouri Neamati. (2013). Small Molecule Inhibitors of CXCR4. Theranostics. 3(1). 47–75. 216 indexed citations
6.
Xu, Shili, Takashi Oshima, Toshio Imada, et al.. (2013). Stabilization of MDA-7/IL-24 for colon cancer therapy. Cancer Letters. 335(2). 421–430. 29 indexed citations
7.
Madhusudan, Srinivasan, et al.. (2012). Purification and Specific Assays for Measuring APE-1 Endonuclease Activity. Methods in molecular biology. 928. 161–174. 2 indexed citations
8.
Wang, Zhe, Peng Huang, Ashwinkumar Bhirde, et al.. (2012). A nanoscale graphene oxide–peptide biosensor for real-time specific biomarker detection on the cell surface. Chemical Communications. 48(78). 9768–9768. 89 indexed citations
9.
Yadav, Mange Ram, Fedora Grande, Prashant Naik, et al.. (2011). Cytotoxic potential of novel 6,7-dimethoxyquinazolines. European Journal of Medicinal Chemistry. 48. 231–243. 19 indexed citations
10.
Tiwari, Keshri Nath, Lionel Quentin, Guy G. Chabot, et al.. (2011). Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells. Bioorganic & Medicinal Chemistry Letters. 21(20). 6195–6197. 34 indexed citations
11.
Cao, Bin, Yong Wang, Kan Ding, Nouri Neamati, & Ya-Qiu Long. (2011). Synthesis of the pyridinyl analogues of dibenzylideneacetone (pyr-dba) via an improved Claisen–Schmidt condensation, displaying diverse biological activities as curcumin analogues. Organic & Biomolecular Chemistry. 10(6). 1239–1245. 20 indexed citations
12.
Oshima, Takashi, Xuefei Cao, Fedora Grande, et al.. (2009). Combination effects of SC144 and cytotoxic anticancer agents. Anti-Cancer Drugs. 20(5). 312–320. 12 indexed citations
13.
Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Eva Musulén, et al.. (2009). Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy. International Journal of Cancer. 124(12). 2905–2910. 60 indexed citations
14.
Gundla, Rambabu, et al.. (2008). Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach. Journal of Medicinal Chemistry. 51(12). 3367–3377. 121 indexed citations
15.
Deng, Jinxia, et al.. (2008). Discovery of Novel Anticancer Compounds Based on a Quinoxalinehydrazine Pharmacophore. ChemMedChem. 3(11). 1677–1686. 8 indexed citations
16.
Al‐Mawsawi, Laith Q., Frauke Christ, Raveendra Dayam, Zeger Debyser, & Nouri Neamati. (2008). Inhibitory profile of a LEDGF/p75 peptide against HIV‐1 integrase: Insight into integrase–DNA complex formation and catalysis. FEBS Letters. 582(10). 1425–1430. 46 indexed citations
17.
Sączewski, Franciszek, et al.. (2006). Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides. Bioorganic & Medicinal Chemistry. 14(9). 2985–2993. 21 indexed citations
18.
Zhao, Qian, Liying Ma, Shibo Jiang, et al.. (2005). Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology. 339(2). 213–225. 177 indexed citations
19.
Kanzaki, Atsuko, Masakazu Toi, Nouri Neamati, et al.. (2002). Copper‐transporting P‐Type Adenosine Triphosphatase (ATP7B) Is Expressed in Human Breast Carcinoma. Japanese Journal of Cancer Research. 93(1). 70–77. 43 indexed citations
20.
Nakayama, Kentaro, Atsuko Kanzaki, Kenji Ogawa, et al.. (2002). Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. International Journal of Cancer. 101(5). 488–495. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Flygare Breakdown of academic impact, for papers by Renato T. Skerlj Breakdown of academic impact, for papers by Jeremy Green Breakdown of academic impact, for papers by Jennifer L. Meagher Breakdown of academic impact, for papers by Joseph M. Covey Breakdown of academic impact, for papers by William T. Windsor Breakdown of academic impact, for papers by Naoyuki Kanzaki Breakdown of academic impact, for papers by László Őrfi Breakdown of academic impact, for papers by Cy A. Stein Breakdown of academic impact, for papers by Anne M. Hassell
Rankless by CCL
2026